KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Times Interest Earned (2018 - 2026)

Castle Biosciences' Times Interest Earned history spans 8 years, with the latest figure at -$159.46 for Q4 2025.

  • On a quarterly basis, Times Interest Earned fell 462.23% to -$159.46 in Q4 2025 year-over-year; TTM through Dec 2025 was -$497.79, a 3102.82% decrease, with the full-year FY2025 number at -$497.79, down 3412.86% from a year prior.
  • Times Interest Earned hit -$159.46 in Q4 2025 for Castle Biosciences, up from -$283.5 in the prior quarter.
  • Over the last five years, Times Interest Earned for CSTL hit a ceiling of $44.02 in Q4 2024 and a floor of -$15171.0 in Q4 2021.
  • Historically, Times Interest Earned has averaged -$3458.9 across 5 years, with a median of -$1642.8 in 2025.
  • Biggest five-year swings in Times Interest Earned: crashed 197543.3% in 2021 and later surged 101.56% in 2024.
  • Tracing CSTL's Times Interest Earned over 5 years: stood at -$15171.0 in 2021, then skyrocketed by 62.38% to -$5708.0 in 2022, then surged by 50.44% to -$2829.0 in 2023, then surged by 101.56% to $44.02 in 2024, then crashed by 462.23% to -$159.46 in 2025.
  • Business Quant data shows Times Interest Earned for CSTL at -$159.46 in Q4 2025, -$283.5 in Q3 2025, and -$202.43 in Q2 2025.